[Is rituximab a promising treatment for Sjögren's syndrome?]

MeSH terms

• Animals
• Anti-Inflammatory Agents / administration & dosage
• Anti-Inflammatory Agents / therapeutic use
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / pharmacology
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Murine-Derived
• Antigens, CD20
• Autoantibodies
• B-Lymphocytes / drug effects
• Clinical Trials as Topic
• Disease Models, Animal
• Drug Resistance
• Drug Therapy, Combination
• France
• Glucocorticoids / administration & dosage
• Glucocorticoids / therapeutic use
• Humans
• Lymphocyte Activation / drug effects
• Methylprednisolone / administration & dosage
• Methylprednisolone / therapeutic use
• Mice
• Multicenter Studies as Topic
• Prednisolone / administration & dosage
• Prednisolone / therapeutic use
• Randomized Controlled Trials as Topic
• Rituximab
• Sjogren's Syndrome / drug therapy*
• Sjogren's Syndrome / immunology
• T-Lymphocytes / drug effects
• Treatment Outcome